NCT01721759 2022-06-28Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic RegimensBristol-Myers SquibbPhase 2 Completed117 enrolled 17 charts